Endoscopist adenomas-per-colonoscopy detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry

Background and Aims: Adenomas per colonoscopy (APC) may be a better measure of colonoscopy quality than adenoma detection rate (ADR) because it credits endoscopists for each detected adenoma. There are few data examining the association between APC and postcolonoscopy colorectal cancer (PCCRC) incidence. We used data from the New Hampshire Colonoscopy Registry to examine APC and PCCRC risk. Methods: We included New Hampshire Colonoscopy Registry patients with an index examination and at least 1 follow-up event, either a colonoscopy or a colorectal cancer (CRC) diagnosis. Our outcome was PCCRC defined fined as any CRC diagnosed >= 6 months after an index examination. The exposure variable was endoscopist-specific APC quintiles of .25, .40, .50, and .70. Cox regression was used to model the hazard of PCCRC on APC, controlled for age, sex, year of index examination, index findings, bowel preparation, and having more than 1 surveillance examination. Results: In 32,535 patients, a lower hazard for PCCRC (n Z 178) was observed for higher APCs as compared to APCs of < .25 (reference): .25 to < .40: hazard ratio (HR), .35; 95% confidence interval (CI), .22-.56; .40 to < .50: HR, .31; 95% CI, .20-.49; .50 to >= .70: HR, .20; 95% CI, .11-.36; and >= .70: HR, .19; 95% CI, .09-.37. When examining endoscopists with an ADR of at least 25%, an APC of < .50 was associated with a significantly higher hazard than an APC of >= .50 (HR, 1.65; 95% CI, 1.06-2.56). A large proportion of endoscopists-one-fifth-one-fifth (32 of 152; 21.1%)- had an ADR of >= 25% but an APC of < .50. Conclusions: Our novel data demonstrating lower PCCRC risk in examinations performed by endoscopists with higher APCs suggest that APC could be a useful quality measure. Quality improvement programs may identify important deficiencies in endoscopist detection performance by measuring APC for endoscopists with an ADR of >= 25%.